| Structure | Chemical Name | CAS | MF |
|
H-ASN-PRO-THR-ASN-LEU-HIS-OH
|
154277-65-3
|
C29H46N10O10
|
|
D-[3-13C]GLYCEROL
|
154278-20-3
|
C3H8O3
|
|
clemontanoside F
|
154278-77-0
|
C54H88O22
|
|
(2S,3S)- 3-hydroxy-2-PyrrolidineMethanol hydrochloride
|
154278-84-9
|
C5H12ClNO2
|
|
Bicyclo[2.2.1]hept-5-ene-2-carboxaldehyde, 2-ethyl-, (1S,2R,4S)- (9CI)
|
154279-11-5
|
C10H14O
|
|
Bicyclo[2.2.1]hept-5-ene-2-carboxaldehyde, 2,3-dimethyl-, (1S,2R,3R,4R)- (9CI)
|
154279-12-6
|
C10H14O
|
|
tert-butyl (1-cyano-2-phenylethyl)carbamate
|
154279-16-0
|
C14H18N2O2
|
|
1,2,3-Butanetriol,4-(2-pyridinylamino)-,(R*,S*)-(9CI)
|
154279-17-1
|
C9H14N2O3
|
|
Cyclohexanamine, 4,4-methylenebisN-(1-methylpropyl)-
|
154279-60-4
|
C21H42N2
|
|
Cyclohexanamine, 4,4-methylenebis2-methyl-N-(1-methylpropyl)-
|
154279-61-5
|
C23H46N2
|
|
Caviton
|
154281-09-1
|
|
|
9-(CHLORODIMETHYLSILYL)-9H-FLUORENE
|
154283-78-0
|
C15H15ClSi
|
|
Pyrrolo[1,2-a]pyrazin-1(2H)-one, 3,4-dihydro-4-phenyl-
|
154283-98-4
|
C13H12N2O
|
|
1-BUTYLINDOLE-3-CARBOXYLIC ACID
|
154287-01-1
|
C13H15NO2
|
|
Arillanin A
|
154287-47-5
|
C33H40O18
|
|
2'-cinnamoyl-3'-benzoyl-(2-O-α-glucosyl)-Sucrose
|
154287-55-5
|
C34H42O18
|
|
4-Chloroquinazolin-8-ol
|
154288-08-1
|
C8H5ClN2O
|
|
4-Chloro-8-methoxyquinazoline
|
154288-09-2
|
C9H7ClN2O
|
|
4-CHLORO-2-METHYL-8-QUINAZOLINOL
|
154288-10-5
|
C9H7ClN2O
|
|
4-CHLORO-8-METHOXY-2-METHYL-QUINAZOLINE
|
154288-17-2
|
C10H9ClN2O
|
|
(N-(1-carboxy-3-(1,3-dihydro-1,3-dioxo-2H-benz(f)isoindol-2-yl)propyl)-leucyl)-N-methyl-phenylalaninamide
|
154296-67-0
|
C32H36N4O6
|
|
3-(9'-mercaptononylthio)-1,1,1,-trifluoropropan-2-one
|
154301-46-9
|
C12H21F3OS2
|
|
2-ethoxy-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)benzimidazole
|
154301-47-0
|
C23H20N6O
|
|
glutamyl-asparaginyl-aspartyl-tyrosyl-isoleucyl-asparaginyl-alanyl-seryl-leucine
|
154301-48-1
|
C44H67N11O18
|
|
ECHISTATIN
|
154303-05-6
|
C217H341N71O74S9
|
|
|
hirustasin
|
154303-69-2
|
|
|
|
stenoxobin
|
154303-71-6
|
|
|
4-Pyridinecarboxylic acid, 4,4'-(1,4-phenylene) ester
|
154306-50-0
|
C18H12N2O4
|
|
Spiroisobenzofuran-1(3H),9-9Hxanthene-2-carboxylic acid, 6-(diethylamino)-3-oxo-, ethyl ester
|
154306-60-2
|
C27H25NO5
|
|
2-Azetidinone, 3-hydroxy-4-phenyl-1-[(1S)-1-phenylethyl]-, (3R,4S)-
|
154306-81-7
|
C17H17NO2
|
|
(2S,5S)-5-hydroxypiperidine-2-carboxylic acid hydrochloride
|
154307-84-3
|
C6H12ClNO3
|
|
1-(Cyanomethyl)-3-methylimidazolium chloride
|
154312-63-7
|
C6H8ClN3
|
|
2-Propenenitrile,3-(1-methyl-1H-imidazol-2-yl)-(9CI)
|
154312-83-1
|
C7H7N3
|
|
4-(Chloromethyl)-1-methylpyrazole Hydrochloride
|
154312-86-4
|
C5H8Cl2N2
|
|
4-amino-2,6-difluoro- Benzoic acid
|
154314-62-2
|
C7H5F2NO2
|
|
Ethyl 2-(1-piperazinyl)pyridine-3-carboxylate
|
154315-70-5
|
C12H17N3O2
|
|
Ethanone, 1-[4-(aminooxy)-2-hydroxyphenyl]- (9CI)
|
154317-49-4
|
C8H9NO3
|
|
2,2-dimethyl-5-(4-nitrobenzyl)-1,3-dioxane-4,6-quinone
|
154317-89-2
|
C13H13NO6
|
|
4‐TERT‐BUTYLPHENYL TRIFLUOROMETHANESULFONATE
|
154318-75-9
|
C11H13F3O3S
|
|
2-Penten-2-ol, 4-hydroperoxy-4-methyl-, (2E)- (9CI)
|
154319-94-5
|
C6H12O3
|
|
2'-hydroxymatteucinol
|
154320-34-0
|
C18H18O6
|
|
Methyl 4-isobutylbenzoate
|
154320-56-6
|
C12H16O2
|
|
(E)-3-DIMETHYLAMINO-1-THIOPHEN-2-YL-PROPENONE
|
154321-55-8
|
C9H11NOS
|
|
4-(2-THIENYL)-2-PYRIMIDINAMINE
|
154321-60-5
|
C8H7N3S
|
|
2-Methyl-4-(thiophen-2-yl)pyriMidine
|
154321-62-7
|
C9H8N2S
|
|
1-[[[3-[2-(DiMethylaMino)ethyl]-1H-indol-5-yl]Methyl]sulfonyl]pyrrolidine Monohydrochloride
|
154323-46-3
|
C17H26ClN3O2S
|
|
Almotriptan
|
154323-57-6
|
C17H25N3O2S
|
|
2-(2-THIENYL)-1,3-THIAZOLE-4-CARBOHYDRAZIDE
|
154323-99-6
|
C8H7N3OS2
|
|
8-(4-tolylsulfinyl)-2,3,4,4a,5,6,7,8-octahydro-4a-quinolinol
|
154325-32-3
|
C16H21NO2S
|
|
2-(4-hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)quinazolin-4(3H)-one
|
154325-51-6
|
C17H11N3O3
|
|
BUTTPARK 146\18-78
|
154325-57-2
|
C11H10N2O3
|
|
ETHYL 5-BROMO-2,2-DIMETHYL-4-OXOPENTANOATE
|
154325-75-4
|
C9H15BrO3
|
|
1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-5-methoxy-ethyl ester
|
154325-76-5
|
C27H34ClNO3S
|
|
ethyl 3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-hydroxy-1H-indol-2-yl)-2,2-dimethylpropanoate
|
154325-77-6
|
C26H32ClNO3S
|
|
7-bromo-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
|
154326-11-1
|
C10H6BrNO3
|
|
4-Fluoro-2(3H)-Benzothiazolethione
|
154327-24-9
|
C7H4FNS2
|
|
4-Fluoro-2-(methylthio)benzo[d]thiazole
|
154327-25-0
|
C8H6FNS2
|
|
2-CHLORO-5-FLUOROBENZOTHIAZOLE
|
154327-27-2
|
C7H3ClFNS
|
|
2-CHLORO-7-FLUOROBENZOTHIAZOLE
|
154327-28-3
|
C7H3ClFNS
|
|
7-Fluoro-3H-benzothiazole-2-thione
|
154327-29-4
|
C7H4FNS2
|
|
Ethyl 6,7-difluoro-2-ethylmercapto-4-hydroxyquinoline-3-carboxylate
|
154330-67-3
|
C14H13F2NO3S
|
|
Ethyl 4-acetoxy-6,7-difluoro-2-(ethylthio)quinoline-3-carboxylate
|
154330-68-4
|
C16H15F2NO4S
|
|
t-butyloxycarbonyl-leucyl-dipropylglycyl-valine methyl ester
|
154331-04-1
|
C25H47N3O6
|
|
ethyl [(1S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl]methanesulfonate
|
154335-57-6
|
C12H20O4S
|
|
Silver sodium zirconium phosphate
|
154339-84-1
|
|
|
2,7-Thianthrenedicarboxylic Acid
|
154341-96-5
|
C14H8O4S2
|
|
2,8-Thianthrenedicarboxylic Acid
|
154341-97-6
|
C14H8O4S2
|
|
L-Proline, 1-ethyl-4-hydroxy-, methyl ester, trans- (9CI)
|
154342-67-3
|
C8H15NO3
|
|
3-chloro-N-(2,5-dimethoxyphenyl)propanamide
|
154343-50-7
|
C11H14ClNO3
|
|
2-CHLORO-5,8-DIMETHOXY-QUINOLINE-3-CARBALDEHYDE
|
154343-51-8
|
C12H10ClNO3
|
|
2′,2′′,4′′′-Trifluor-4-propyl-1,1′:4′,1′′-terphenyl
|
154346-21-1
|
C21H17F3
|
|
Oxiranecarboxylic acid, 2-acetyl-, ethyl ester (9CI)
|
154346-53-9
|
C7H10O4
|
|
5-{[(4-methylphenyl)methyl]sulfanyl}-1,3,4-thiadiazol-2-amine
|
154347-43-0
|
C10H11N3S2
|
|
tert-butyl 1-oxo-2-oxa-8-azaspiro[4.5]decane-8-carboxylate
|
154348-08-0
|
C13H21NO4
|
|
Ethanethioamide, N-methyl-N-(phenylmethyl)-
|
154349-19-6
|
C10H13NS
|
|
CYCLOPROPANESULPHONAMIDE
|
154350-28-4
|
C3H7NO2S
|
|
Cyclopropanesulfonamide
|
154350-29-5
|
C3H7NO2S
|
|
4-(3-Formyl-indol-1-yl)-benzoic acid tert-butyl ester
|
154350-90-0
|
C20H19NO3
|
|
2-(4-Hydroxymethylphenyl)isonicotinic acid
|
154352-41-7
|
C14H13NO3
|
|
Benzenepropanamide, alpha-fluoro-N,N-dimethyl-beta-oxo- (9CI)
|
154353-55-6
|
C11H12FNO2
|
|
8-methoxycarbonyloctyl-3-O-glucopyranosyl-mannopyranoside
|
154354-46-8
|
C22H40O13
|
|
ATRELEUTON
|
154355-75-6
|
C16H15FN2O2S
|
|
1-[(2R)-4-[5-[(4-fluorophenyl)methyl]thiophen-2-yl]but-3-yn-2-yl]-1-hydroxy-urea
|
154355-76-7
|
C16H15FN2O2S
|
|
Thiophene, 2-[(4-fluorophenyl)Methyl]-5-iodo-
|
154355-88-1
|
C11H8FIS
|
|
22-dehydro-1,25-dihydroxy-24-dihomovitamin D3
|
154356-84-0
|
C29H46O3
|
|
(4-Chlorophenyl)[4-(1-Methylethoxy)phenyl]Methanone (Fenofibrate IMpurity)
|
154356-96-4
|
C16H15ClO2
|
|
Fenofibric acid-002
|
154356-97-5
|
C16H15ClO2
|
|
(S)-(-)-Nadifloxacin
|
154357-42-3
|
C19H21FN2O4
|
|
3-trifluoromethyl-1H-5-chloropyrazole-4-Carbaldehyde
|
154357-44-5
|
C5H2ClF3N2O
|
|
TRIMETHYLPHOSPHONIUM TETRAFLUOROBORATE
|
154358-50-6
|
C3H10BF4P
|
|
|
Arcitumomab
|
154361-48-5
|
|
|
Capecitabine
|
154361-50-9
|
C15H22FN3O6
|
|
Desmethoxyacetyliopromid
|
154361-51-0
|
C15H20I3N3O6
|
|
Iopromide EP Impurity C
|
154361-52-1
|
C17H22I3N3O8
|
|
Iopromide EP Impurity G
|
154361-53-2
|
C18H23ClI3N3O7
|
|
Iopromide EP Impurity F
|
154361-54-3
|
C21H28I3N3O9
|
|
Iopromide EP Impurity D
|
154361-55-4
|
C36H46I6N6O15
|
|
(Gly21)-Amyloid β-Protein (1-40)
|
154362-03-5
|
C19H12FN5O3S2
|
|
ETHYL 6-ETHOXY-2-HYDROXYBENZOATE 95
|
154364-61-1
|
C11H14O4
|
|
ETHYL 2-METHYL-3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZINE-2-CARBOXYLATE
|
154365-33-0
|
C12H13NO4
|